Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Cyclerion Therapeutics (CYCN) Receivables - Other (2019 - 2020)

Cyclerion Therapeutics (CYCN) has disclosed Receivables - Other for 2 consecutive years, with $127000.0 as the latest value for Q4 2020.

  • For Q4 2020, Receivables - Other fell 91.38% year-over-year to $127000.0; the TTM value through Dec 2020 reached $127000.0, down 91.38%, while the annual FY2020 figure was $100000.0, 93.22% down from the prior year.
  • Receivables - Other hit $127000.0 in Q4 2020 for Cyclerion Therapeutics, down from $400000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $1.6 million in Q2 2019 and bottomed at $127000.0 in Q4 2020.